Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maximilian Brunner

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
Molecular Cancer|February 2, 2024
Discrimination of pancreato-biliary cancer and pancreatitis patients by non-invasive liquid biopsyChristina Hartwig, Jan Müller, Hagen Klett, et al.
Cancers|January 21, 2023
Circulating Monocytes Serve as Novel Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma PatientsFrederik J Hansen, Paul David, Marina Akram, et al.
International Journal of Molecular Sciences|April 17, 2025
Increased Herpesvirus Entry Mediator Expression on Circulating Monocytes and Subsets Predicts Poor Outcomes in Pancreatic Ductal Adenocarcinoma PatientsIsabelle Kuchenreuther, Finn-Niklas Clausen, Johanne Mazurie, et al.
International Journal of Molecular Sciences|May 14, 2022
Tumor Infiltration with CD20<sup>+</sup>CD73<sup>+</sup> B Cells Correlates with Better Outcome in Colorectal CancerFrederik J Hansen, Zhiyuan Wu, Paul David, et al.
International Journal of Molecular Sciences|June 12, 2026
Post-Surgical Remodeling of Circulating Monocytes Identifies CD86 Expression on Non-Classical Monocytes as a Prognostic Indicator in Pancreatic Ductal AdenocarcinomaLisa-Sophie Arnold, Anne Jacobsen, Isabelle Kuchenreuther, et al.
Cells|March 14, 2026
Immune Cell-Specific and Isoform-Selective Regulation of CD44 in Pancreatic Ductal Adenocarcinoma Links Lymph Node Variant Loss and Exosomal CD44 to Clinical Outcome in Pancreatic Ductal AdenocarcinomaAlara Karabiber, Yong Zhou, Anke Mittelstädt, et al.
The British Journal of Surgery|November 8, 2021
Pancreatoduodenectomy with or without prophylactic falciform ligament wrap around the hepatic artery for prevention of postpancreatectomy haemorrhage: randomized clinical trial (PANDA trial)Thilo Welsch, Benjamin Müssle, Sandra Korn, et al.
Frontiers in Immunology|June 7, 2024
Exosomal ROR1 in peritoneal fluid identifies peritoneal disseminated PDAC and is associated with poor survivalAnke Mittelstädt, Anna Anthuber, Paul David, et al.
Scientific Reports|September 10, 2024
CD71 expressing circulating neutrophils serve as a novel prognostic biomarker for metastatic spread and reduced outcome in pancreatic ductal adenocarcinoma patientsFrederik J Hansen, Anke Mittelstädt, Finn-Niklas Clausen, et al.
Nature Communications|February 19, 2021
Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infectionsAlan Bénard, Anne Jacobsen, Maximilian Brunner, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Molecular Cancer|February 2, 2024
Discrimination of pancreato-biliary cancer and pancreatitis patients by non-invasive liquid biopsyChristina Hartwig, Jan Müller, Hagen Klett, et al.
Cancers|January 21, 2023
Circulating Monocytes Serve as Novel Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma PatientsFrederik J Hansen, Paul David, Marina Akram, et al.
International Journal of Molecular Sciences|April 17, 2025
Increased Herpesvirus Entry Mediator Expression on Circulating Monocytes and Subsets Predicts Poor Outcomes in Pancreatic Ductal Adenocarcinoma PatientsIsabelle Kuchenreuther, Finn-Niklas Clausen, Johanne Mazurie, et al.
International Journal of Molecular Sciences|May 14, 2022
Tumor Infiltration with CD20<sup>+</sup>CD73<sup>+</sup> B Cells Correlates with Better Outcome in Colorectal CancerFrederik J Hansen, Zhiyuan Wu, Paul David, et al.
International Journal of Molecular Sciences|June 12, 2026
Post-Surgical Remodeling of Circulating Monocytes Identifies CD86 Expression on Non-Classical Monocytes as a Prognostic Indicator in Pancreatic Ductal AdenocarcinomaLisa-Sophie Arnold, Anne Jacobsen, Isabelle Kuchenreuther, et al.
Cells|March 14, 2026
Immune Cell-Specific and Isoform-Selective Regulation of CD44 in Pancreatic Ductal Adenocarcinoma Links Lymph Node Variant Loss and Exosomal CD44 to Clinical Outcome in Pancreatic Ductal AdenocarcinomaAlara Karabiber, Yong Zhou, Anke Mittelstädt, et al.
The British Journal of Surgery|November 8, 2021
Pancreatoduodenectomy with or without prophylactic falciform ligament wrap around the hepatic artery for prevention of postpancreatectomy haemorrhage: randomized clinical trial (PANDA trial)Thilo Welsch, Benjamin Müssle, Sandra Korn, et al.
Frontiers in Immunology|June 7, 2024
Exosomal ROR1 in peritoneal fluid identifies peritoneal disseminated PDAC and is associated with poor survivalAnke Mittelstädt, Anna Anthuber, Paul David, et al.
Scientific Reports|September 10, 2024
CD71 expressing circulating neutrophils serve as a novel prognostic biomarker for metastatic spread and reduced outcome in pancreatic ductal adenocarcinoma patientsFrederik J Hansen, Anke Mittelstädt, Finn-Niklas Clausen, et al.
Nature Communications|February 19, 2021
Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infectionsAlan Bénard, Anne Jacobsen, Maximilian Brunner, et al.
Pageof 11